Search for: "Sanofi" Results 221 - 240 of 1,195
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2017, 5:15 am by Steve Brachmann
The major impetus behind this suit was Sanofi-Aventis and Regeneron’s discovery that Amgen hired litigation counsel to assert the ‘487 patent and is also working on retaining experts. [read post]
5 Oct 2017, 11:24 am
"U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent": Brendan Pierson of Reuters has this report on a ruling that the U.S. [read post]
23 Mar 2006, 10:15 pm
Bristol-Myers Squibb Company and sanofi-aventis announced earlier this week that they have reached a tentative settlement agreement with Apotex Inc. and Apotex Corp. regarding the pending Plavix ® patent infringement lawsuit. [read post]
17 Jan 2008, 5:30 pm
Ramipril, by Sanofi-Aventis is an angiotensin-converting enzyme (ACE) inhibitor, used to treat hypertension and congestive heart failure. [read post]
16 Sep 2010, 11:46 am by Tom Huddleston Jr.
Genzyme reached an agreement to sell its Genzyme Genetics unit to LabCorp in the midst of buyout talks with Sanofi-Aventis. [read post]
18 Feb 2011, 3:00 am by Tom Huddleston Jr.
Aiello led the team advising longtime Weil client Sanofi-Aventis on its $20.1 billion takeover of Genzyme. [read post]
27 Feb 2020, 10:25 am by Dennis Crouch
The court explains: The principal questions posed on this appeal are whether Sanofi improperly submitted a patent for listing in the Orange Book and, if so, whether Sanofi is potentially liable under the antitrust laws to drug purchasers who were allegedly harmed by the effective extension of Sanofi’s monopoly. [read post]
17 Feb 2007, 7:58 am
One of the biggest challenges was to prevent Sanofi's attorneys from slowing the case, the Stradling lawyers said. [read post]
12 Jan 2021, 7:26 am
The transaction sees French pharma giant Sanofi acquire U.K. biotech firm Kymab. [read post]
23 Dec 2010, 7:48 am by Lawrence B. Ebert
In the Sanofi-Aventis case over generic oxaliplatin , the CAFC wrote:We find that Section 3.5 of the license agreement is objectively ambiguous. [read post]
16 Jan 2021, 9:58 pm by Patent Docs
The panel will discuss the Federal Circuit decisions in Sanofi v. [read post]
14 Jan 2011, 8:21 am by Ronald V. Miller, Jr.
Bristol-Myers co-markets Avalide and another blood pressure medication, Sanofi-Aventis' Avapro, under a longstanding partnership. [read post]
13 Sep 2008, 4:35 am
According to Sanofi-Aventis' July 18 filing with the House clerk's office, the drugmaker's lobbying efforts were directed in part at follow-on biologics legislation. [read post]
10 May 2011, 4:24 pm by Aaron Barkoff
In a press release today, the Federal Trade Commission announced that it "has notified Sanofi-Aventis U.S. [read post]
29 Jan 2008, 3:13 pm
Sanofi-Aventis spokeswoman Julissa Viana repeated earlier comments saying Aventis was not aware of the fraud in Study 3014 until after it was submitted to the FDA. [read post]